March/April 2022

Biopharma Asia

March/April 2022 | Volume 11 Issue 2


Data as an Asset: What Does this Mean to You?

Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...


Developing a Leading Edge with PAT

Martin Gadsby, Owner, Optimal Industrial Automation Ltd


Risk-Based Extractable Data Assessment and its Application to the Evaluation of Materials ...

Ping Wang Ph.D., MBA, Scientific Director, Janssen


Supply Chain Security Risks

Brian Johnson, Senior Director of Supply Chain Security, Pfizer Pharmaceuticals / Chair o...


Applications of SFC in Pharmaceutical Analysis

Gregory Webster, Senior Principal Research Scientist, AbbVie Inc


Transforming Scientists into Drug Developers

Clive Glover, General Manager, Gene Therapy, Pall James Taylor, Co-founder and GM, Precisi...